Skip to Main Content

Paper Details

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.
J Clin Invest
98
2019
CRPC, CRPC tumor, CRPC tumors, FOXA1, FOXA1 protein, LY2157299, PC, PC cells, Prostate cancer, SMAD2, TGF, TGF-, TGF- receptor I, TGFB3, TGFB3 gene, basal, castration-resistant prostate cancer, enzalutamide, epithelial lineage, galunisertib, primary tumors, transforming growth factor beta 3, upstream enhancer
Author NameAffiliation
Robert L VessellaUniversity of Washington
Colm MorrisseyUniversity of Washington
Timothy M Kuzel
  • 1 - 3

Datasets

Release 1.2